Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ataraxia Partners is a venture capital firm founded to improve the quality of life across North America, Europe, and Asia. The firm operates under the overarching thesis of enhancing human wellbeing, which is reflected in its name derived from the Greek word for tranquility and freedom from mental distress. Established with roots in 2011 through Social Starts, Ataraxia has evolved to encompass multiple fund families, including Joyance Partners and SH² — The Science of Health and Happiness.
Currently headquartered in San Francisco, CA, Ataraxia Partners manages a diverse portfolio of over 300 companies. The firm employs a data-driven methodology supported by a proprietary machine learning platform that identifies promising startup signals. This research-intensive approach allows Ataraxia to make informed early-stage investments, focusing on sectors that align with their mission of cultivating joy through science and technology.
Ataraxia Partners invests primarily in the health and consumer sectors, targeting early-stage companies from pre-seed to Series A. Their investment strategy emphasizes the cultivation of joy, which they define in personal, societal, and universal contexts. Key focus areas include personal health, beauty, food and drink, techbio, and sustainability. The firm seeks startups that align with their mission of enhancing human wellbeing and are positioned to deliver innovative solutions in these sectors.
Investment checks typically range from early seed funding to Series A rounds, allowing Ataraxia to support companies at various stages of their development. The firm’s geographic focus spans North America, Europe, and Asia, reflecting a commitment to identifying and nurturing startups that can make a significant impact on health and consumer products globally.
Ataraxia Partners boasts a diverse portfolio of notable companies, including:
This portfolio reflects Ataraxia's commitment to enhancing quality of life through strategic investments in innovative companies across various sectors.
Mike Edelhart: Managing Partner at Ataraxia Partners, Mike has extensive experience in venture capital and has been instrumental in the firm's strategic direction. He has a background in technology investments and has led numerous successful funding rounds across various sectors.
Submit your pitch through their website's contact form for consideration.
In recent months, Ataraxia Partners has made several notable investments, particularly in the beauty and health sectors. New additions to their portfolio include Exponent Beauty, Alba Health, and Altr Beauty, reflecting the firm's commitment to enhancing quality of life through strategic investments. Their portfolio currently includes nine companies, showcasing their active engagement in identifying and supporting innovative startups.
What are Ataraxia Partners' investment criteria?
Ataraxia Partners focuses on early-stage companies in the health and consumer sectors, particularly those that align with their mission of enhancing human wellbeing. They invest from pre-seed to Series A stages, targeting startups that demonstrate potential for significant impact in personal health, beauty, food and drink, techbio, and sustainability.
How can I apply or pitch to Ataraxia Partners?
Founders interested in pitching to Ataraxia Partners should prepare a comprehensive pitch deck that outlines their business model, market opportunity, and alignment with Ataraxia's investment thesis. While specific application forms or portals are not mentioned, reaching out through their official website or networking within the industry may facilitate introductions.
What makes Ataraxia Partners different from other venture capital firms?
Ataraxia Partners distinguishes itself through its data-driven investment methodology, utilizing a proprietary machine learning platform to identify promising startups. This research-intensive approach ensures thorough analysis and support for early-stage investments, focusing on companies that enhance health and happiness.
What is the geographic scope of Ataraxia Partners' investments?
The firm invests in companies across North America, Europe, and Asia, reflecting a global perspective on health and consumer innovations. This broad geographic focus allows Ataraxia to tap into diverse markets and identify startups with the potential for significant impact.
What is the typical check size for investments made by Ataraxia Partners?
Ataraxia Partners invests in early-stage companies, typically providing funding from pre-seed to Series A rounds. While specific check sizes are not disclosed, the firm focuses on supporting startups at various stages of their development.
What kind of post-investment involvement does Ataraxia Partners have with portfolio companies?
Ataraxia Partners employs a research-intensive approach to support its portfolio companies, leveraging their proprietary machine learning platform to provide insights and guidance. This involvement may include strategic advice, operational support, and assistance in scaling their businesses.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.